Versant™ HCV
Siemens Health Care Diagnostics Semi-automated TMA 10
Quantitative HCV RNA detection assays Amplicor™ HCV Monitor Roche Molecular System Manual RT-PCR 600-500,000
Cobas Amplicor™ HCV Monitor 2.0 Roche Molecular System Semi-automated RT-PCR 600-500,000 Jeong Heo. Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response 181 (Table 2) . [5] [6] [7] [8] [9] [10] [11] [12] [13] On the other hand, earlier reports showed higher rate of late relapse. [14] [15] [16] These discrepancies may be resulted from use of HCV polymerase chain reaction (PCR) assays with varying degrees of sensitivity and a range of patient populations.
As a result, the true durability of the response remains unclear, and the optimal follow-up for patients who have achieved an SVR is unknown.
Even then achievement of an SVR, there are many evidences that HCV can persist and replicate in peripheral blood mononuclear cells, hepatic tissue and other organs including kidney, heart, pancreas, intestine, adrenal gland, lymph node and gallbladder in spite of still undetectable serum HCV RNA. 3, [17] [18] [19] [20] [21] It is so called "occult HCV", which can be reservoir of reappearance HCV RNA in serum 3, 21 
